Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Repurchase of Common Stock

Rigel Pharmaceuticals Repurchase of Common Stock Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Repurchase of Common Stock from 2020 to 2020.
Other Cash Flow Metrics:
  • Rigel Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $12m a 300.91% increase of 35m year over year
  • Rigel Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $1m a 1,495.75% increase of 15m year over year
  • Rigel Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $5m a 26.33% increase of 1m year over year
View Chart On Koyfin